$6.300
-0.010 (-0.16%)At close
BHC News
BHC Events
Dow Rises While Nasdaq Falls
The major averages were mixed, with the Dow rising and the Nasdaq falling, as investors get ready for what is widely expected to be another strong corporate earnings season.The focus now shifts to third-quarter earnings, with JPMorgan Chase, Wells Fargo, Goldman Sachs and Citigroup set to report Tuesday. Analysts are expecting strong year-over-year earnings growth for S&P 500 companies, with AI-related spending and growth continuing to support the outlook. Investors also will be watching September inflation figures, with consumer and producer inflation reports set to hit late in the week.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiais in talks to either acquire or increase its investment in Reflection AI, FT reportsAmazonis in discussions to acquire AI startup Decart for $7B, WSJ reportsIonQagreed to acquire Elisity in an up to $1.3B all-stock transactionA Starbucksspokesperson told CNBC the company is not buying ChipotleBumbleis in advanced talks to go private at a $1B valuation, WSJ reports2. WALL STREET CALLS:Salesforcedouble upgraded to Buy from Underperform at BofAAdobedouble downgraded to Underweight from Overweight at Wells FargoRaymond James upgraded T-Mobileto Outperform, calls recent fears over competition from SpaceX"overblown"GoDaddydowngraded to Sector Perform at RBC CapitalTruist upgraded First Solarto Buy on strong pricing backdrop3. AROUND THE WEB:IntelCEO Lip-Bu Tan said that the costs of Chinese AI models have lowered, and adoption has been "very fast," Reuters reportsGTCR and Elliott Investment Management are in advanced talks to acquire car insurance software provider CCC Intelligent Solutions, and a deal could potentially be announced as soon as this week, Bloomberg reportsSynopsysis exploring partnerships with Chinese AI labs to develop AI-powered chip design tools for the Chinese market, Nikkei Asia reportsSVRN'stransformation from a small shipping company into a NEAR token treasury and SovereignAI business raises significant governance, dilution, valuation, and disclosure concerns, Fugazi Research tells investorsAnthropic CEO Dario Amodei sought additional computing capacity from Metaearlier this year, but after considering the request, Meta ultimately decided not to supply Anthropic with chips for now, WSJ says4. MOVERS:First Tracks Biotherapeuticsgains after reporting results from its Cohort 1 trial of ANB033AST SpaceMobileincreases after Deutsche Bank upgraded the stock to BuyMetawas higher after the company introduced the Muse Wonder seriesTTM Technologieslower after announcing plans to invest $400M to expand its capacity at four facilities in ChinaAmprius Technologiesfalls after filing an automatic mixed securities shelf5. EARNINGS/GUIDANCE:Bausch + Lomband Bausch Healthare expected to raise FY26 adjusted EBITDAEnovixreported preliminary Q3 results, with revenue beating consensusTormraised its outlook for FY26ASE Technologyreported Q3 revenue higher year-over-yearTSMCto report Q3 results on October 15INDEXES:The Dow rose 195.60, or 0.38%, to 51,850.55, the Nasdaq lost 120.27, or 0.44%, to 27,245.90, and the S&P 500 declined 4.30, or 0.06%, to 7,807.24.
Major Averages Mixed as Investors Eye Earnings Season
The major averages were mixed near noon as investors weigh rising oil prices and geopolitical risks against expectations for another strong corporate earnings season. Brent crude reached a roughly two-week high after deadly strikes on Riyadh's international airport over the weekend, while uncertainty surrounding the conflict involving Iran continues to cloud the outlook for global energy supplies.The focus now shifts to third-quarter earnings, with JPMorgan Chase, Wells Fargo, Goldman Sachs and Citigroup set to report Tuesday. Analysts are expecting strong year-over-year earnings growth for S&P 500 companies, with AI-related spending and growth continuing to support the outlook. Investors are also watching September inflation figures, with CPI due Wednesday and PPI and retail sales scheduled for Thursday.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiais in talks to either acquire or increase its investment in Reflection AI, FT reportsAmazonis in discussions to acquire AI startup Decart for $7B, WSJ reportsIonQagreed to acquire Elisity in an up to $1.3B all-stock transactionA Starbucksspokesperson told CNBC the company is not buying ChipotleIntelCEO Lip-Bu Tan said that the costs of Chinese AI models have lowered, and adoption has been "very fast," Reuters reports2. WALL STREET CALLS:Salesforcedouble upgraded to Buy from Underperform at BofAAdobedouble downgraded to Underweight from Overweight at Wells FargoRaymond James upgraded T-Mobileto Outperform, calls recent fears over competition from SpaceX"overblown"GoDaddydowngraded to Sector Perform at RBC CapitalTruist upgraded First Solarto Buy on strong pricing backdrop3. AROUND THE WEB:GTCR and Elliott Investment Management are in advanced talks to acquire car insurance software provider CCC Intelligent Solutions, and a deal could potentially be announced as soon as this week, Bloomberg reportsHSBCplans to phase out fixed-pay allowances for senior staff and instead give them a bigger portion of its compensation through bonuses, Bloomberg saysSynopsysis exploring partnerships with Chinese AI labs to develop AI-powered chip design tools for the Chinese market, Nikkei Asia reportsSVRN'stransformation from a small shipping company into a NEAR token treasury and SovereignAI business raises significant governance, dilution, valuation, and disclosure concerns, Fugazi Research tells investorsAnthropic CEO Dario Amodei sought additional computing capacity from Metaearlier this year, but after considering the request, Meta ultimately decided not to supply Anthropic with chips for now, WSJ says4. MOVERS:First Tracks Biotherapeuticsgains after reporting results from its Cohort 1 trial of ANB033AST SpaceMobileincreases after Deutsche Bank upgraded the stock to BuyC3 AIhigher after Northland upgraded the stock to OutperformTTM Technologieslower after announcing plans to invest $400M to expand its capacity at four facilities in ChinaAmprius Technologiesfalls after filing an automatic mixed securities shelf5. EARNINGS/GUIDANCE:Bausch + Lomband Bausch Healthare expected to raise FY26 adjusted EBITDAEnovixreported preliminary Q3 results, with revenue beating consensusTormraised its outlook for FY26ASE Technologyreported Q3 revenue higher year-over-yearTSMCto report Q3 results on October 15INDEXES:Near midday, the Dow was up 252.66, or 0.49%, to 51,907.61, the Nasdaq was down 60.01, or 0.22%, to 27,306.16, and the S&P 500 was up 2.59, or 0.03%, to 7,814.13.
Bausch + Lomb Expects 2026 Adjusted EBITDA Growth
Based on preliminary third-quarter results, Bausch + Lomb (BLCO) and Bausch Health (BHC) currently expect to raise full-year 2026 adjusted EBITDA excluding Acquired IPR&D guidance. The companies are currently in a blackout period and will provide additional details when they report third-quarter results on Oct. 28.
Bausch + Lomb Appoints Thomas Appio as Interim CEO
Bausch + Lomb (BLCO) and its parent company, Bausch Health (BHC), announced that Bausch + Lomb Board of Directors Chairman Thomas Appio has been appointed interim chief executive officer, effective immediately. Appio will continue to serve as CEO of Bausch Health while assuming leadership of Bausch + Lomb. Appio was appointed chairman of the Bausch + Lomb Board of Directors in August 2026. The Board believes Appio's deep knowledge of the business, global leadership experience and longstanding connection to Bausch + Lomb position him well to build on the company's momentum and lead its next phase of growth.
Bausch Health and YUN Expand Strategic Collaboration in Mexico and EMEA Markets
Bausch Health and YUN, a Belgian company dealing in probiotherapeutical skincare products, announced the continued expansion of their strategic collaboration in Mexico and across additional EMEA markets following the 2025 launch in Poland. The expansion includes both portfolio and geographic growth in recent months. In Poland, Bausch Health expanded its dermatology portfolio to include YUN's eczema-prone skincare solutions. Geographic expansion has included launches of YUN's acne- and eczema-prone skincare solutions in the Czech Republic, Slovakia, Ukraine, Bulgaria, along with the introduction of YUN's skincare solutions in Mexico. The rollout is expected to continue in Kazakhstan in October. This next phase of the collaboration reflects both companies' shared ambition to expand access to science-led, microbiome-friendly skincare solutions across EMEA and select international growth markets.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.








